1.       Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J, Amaral AP, Faul C, Taniguchi M, Wolf M, Brand M, Takahashi M, Kuro-O M, Hill JA, Moe OW. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. Journal of the American Society of Nephrology 2014 (pii:ASN.2014050465).

2.     GS Di Marco, S Reuter, D Kentrup, A Grabner, AP Amaral, M Fobker, J Stypmann, H Pavenstädt, M Wolf, C Faul, M Brand. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CDK. Nephrology Dialysis Transplantation 2014 (pii:gfu190).

3.     JS Padberg, A Wiesinger, GS Di Marco, S Reuter, A Grabner, D Kentrup, A Lukasz, H Oberleithner, H Pavenstädt, M Brand, P Kümpers. Damage of the endothelial glycocalyx in chronic kidney disease.Atherosclerosis, 234:335-343, 2014.

4.    GS Di Marco, H Pavenstädt, M Brand.Soluble Flt-1 release response to heparin use: implications for dialysis patients?Nephrology Dialysis Transplantation, 29(6):1112-5, 2014.

5.   V Barterls, U Hillebrand, M Kosch, M Hausberg, K Kisters, GS Di Marco, S Reiermann, H Pavenstaedt, D Lang. Influence of erytrhopoietin on arterial stiffness and endothelial function in renal transplant recipients. American Journal of Nephrology, 36(4):355-61, 2012.

6.   GS Di Marco, M König, S Stock, A Wiesinger, U Hillebrand, S Reiermann, S Reuter, S Amler, G Köhler, F Buck, M Fobker, P Kümpers, H Oberleithner, M Hausberg, D Lang, H Pavenstädt, M Brand. High phosphate directly affects endothelial function by downregulating annexin II. Kidney International, 83(2):213-222, 2013.

7. M Brand, HPavenstädt. Update kardiorenales Syndrom im herzinsuffizienten Patienten. Nephro News, 11:13-19, 2011.

8.    C Faul, AP Amaral, B Oskouei, MC Hu, A Sloan, T Isakova, OM Gutiérrez, R Aguillon-Prada, J Lincoln, JM Hare, P Mundel, A Morales, J Scialla, M Fischer, EZ Soliman, J Chen, AS Go, SE Rosas, L Nessel, RR Townsend, HI Feldman, M St John Sutton, A Ojo, C Gadegbeku, GS Di Marco, S Reuter, D Kentrup, K Tiemann, M Brand, JA Hill, OW Moe, M Kuro-O, JW Kusek, MG Keane, M Wolf. FGF23 induces left ventricular hypertrophy.Journal of Clinical Investigation, 121(11):4393-408, 2011.

9.  GS Di Marco, P Rustemeyer, M Brand, R Koch, D Kentrup, A Grabner, B Greve, W Wittkowski, H Pavenstädt, M Hausberg, S Reuter, D Lang. Circulating endothelial progenitor cells in kidney transplant patients. PLoS One, 6(9):e24046, 2011.

10.   GS Di Marco, S Reuter, D Kentrup, L Ting, L Ting, A Grabner, AM Jacobi, H Pavenstädt, HA Baba, K Tiemann, M Brand. Cardioprotective effect of calcineurin inhibition in an animal model of renal disease. European Heart Journal, 32(15):1935-45, 2011.

11.  GS Di Marco, M Brand. Letter by Di Marco and Brand regarding article, Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.Circulation, 122(5):e416, 2010.

12.  GS Di Marco, S Reuter, U Hillebrand, S Amler, M König, E Larger, H Oberleithner, E Brand, H Pavenstädt, M Brand.Soluble VEGF receptor Flt1 (sFlt-1) contributes to endothelial dysfunction in chronic kidney disease. Journal of the American Society of Nephrology, 20(10):2235-45,2009.

13.  GS Di Marco, M Hausberg M, U Hillebrand, P Rustemeyer, W Wittkowski, D Lang, H Pavenstädt. Inorganic phosphate induces human endothelial cell apoptosis in vitro. American Journal of Physiology Renal Physiology, 294(6):F1381-7, 2008.